Maurer's cleft Tables

<p><b>Table S1. Table of the human proteins identified by mass spectrometry of purified Maurer’s clefts</b></p><p>A list of human proteins that were identified as being enriched in the REX1-GFP Maurer’s cleft pull downs compared to wild type 3D7. Only proteins that had more than 2 significant MS/MS peptides in 2 separate experiments are shown. A complete list of proteins can be found in Data set1.</p><p> </p><p><b>Table</b><b>S2. Proteins identified by LC-MS/MS analysis of MAHRP1-GFP co-IP </b></p><p>A list of parasite proteins that were identified as being enriched at least 5X in the MAHRP1-GFP IPs compared to the wild type 3D7 controls. Only proteins that had more than 2 significant MS/MS peptides in 2 separate experiments are shown. A complete list of proteins can be found in Data set2.</p><p><b> </b></p><p><b>Table</b><b>S3. Proteins identified by LC-MS/MS analysis of VCAP1-GFP co-IP </b></p><p>A list of parasite proteins that were identified as being enriched at least 5X in the VCAP11-GFP IPs compared to the wild type 3D7 controls. Only proteins that had more than 2 significant MS/MS peptides in 2 separate experiments are shown. A complete list of proteins can be found in Data set 3.</p><p><b> </b></p><p><b>Table</b><b>S4. Proteins identified by LC-MS/MS analysis of GEXP10-GFP co-IP</b></p><p>A list of parasite proteins that were identified as being enriched at least 5X in the GEXP10-GFP IPs compared to the wild type 3D7 controls. Only proteins that had more than 2 significant MS/MS peptides in 2 separate experiments are shown. A complete list of proteins can be found in Data set 4.</p><p><b> </b></p><p><b>Table</b><b>S5. Proteins identified by LC-MS/MS analysis of REX1-GFP co-IP</b></p><p>A list of parasite proteins that were identified as being enriched at least 5X in the REX1-GFP IPs compared to the wild type 3D7 controls. Only proteins that had more than 2 significant MS/MS peptides in 2 separate experiments are shown. A complete list of proteins can be found in Data set 5.</p><p><b> </b></p><p><b>Table</b><b>S6. Proteins identified by LC-MS/MS analysis of PTP5-GFP co-IP</b></p><p>A list of parasite proteins that were identified as being enriched at least 5X in the PTP5-GFP IPs compared to the wild type 3D7 controls. Only proteins that had more than 2 significant MS/MS peptides in 2 separate experiments are shown. A complete list of proteins can be found in Data set 6.</p><p><b> </b></p><p><b>Table</b><b>S7. Proteins identified by LC-MS/MS analysis of <i>PF</i>3D7_1353100 -GFP co-IP</b></p><p>A list of parasite proteins that were identified as being enriched at least 5X in the <i>PF</i>3D7_1353100<b></b>IPs compared to the wild type 3D7 controls. Only proteins that had more than 2 significant MS/MS peptides in 2 separate experiments are shown. A complete list of proteins can be found in Data set 7.</p><p><b> </b></p><p><b>Table</b><b>S8. Proteins identified by LC-MS/MS analysis of PTP6-GFP co-IP</b></p><p>A list of parasite proteins that were identified as being enriched at least 5X in the PTP6-GFP IPs compared to the wild type 3D7 controls. Only proteins that had more than 2 significant MS/MS peptides in 2 separate experiments are shown. A complete list of proteins can be found in Data set 8.</p><p><b> </b></p><p><b>Table S9 Table of primers using in this study</b></p><p>Primer name, restriction site and sequence from 5’ to 3’ are shown.</p>